Zentalis Pharmaceuticals (ZNTL) Interest Coverage Ratio (2019 - 2026)

Zentalis Pharmaceuticals' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 0.73 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 5.53% year-over-year to 0.73 in Q1 2026; TTM through Mar 2026 was 2.81, a 22.13% increase from a year earlier, with the FY2025 full-year figure at 22.47, down 2803.38% from the prior year.
• Interest Coverage Ratio improved to 0.73 in Q1 2026 per ZNTL's latest filing, from 3399.36 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 0.2 in Q4 2024 and bottomed at 3399.36 in Q4 2025.
• The 5-year median for Interest Coverage Ratio is 1.25 (2023), against an average of 215.15.
• Across the five-year window, Interest Coverage Ratio soared 98.95% in 2022 and tumbled 1684442.92% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 0.73 in 2022, then plunged by 1354.03% to 10.61 in 2023, then surged by 98.1% to 0.2 in 2024, then tumbled by 1684442.92% to 3399.36 in 2025, then surged by 99.98% to 0.73 in 2026.
• Per Business Quant, the three latest ZNTL Interest Coverage Ratio figures stand at 0.73 (Q1 2026), 3399.36 (Q4 2025), and 2.27 (Q3 2025).